![]()
Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | 1,2-dimethylhydrazine | increases expression | ISO | RGD:1318708 | 6480464 | 1, 2-Dimethylhydrazine results in increased expression of DLG5 mRNA | CTD | PMID:22206623 | 17beta-estradiol | multiple interactions | ISO | RGD:1318707 | 6480464 | [Estradiol co-treated with Progesterone] results in increased expression of DLG5 mRNA | CTD | PMID:20660070 | 17beta-estradiol | increases expression | ISO | RGD:1318707 | 6480464 | Estradiol results in increased expression of DLG5 mRNA | CTD | PMID:23019147, PMID:31614463 | 17beta-hydroxy-17-methylestra-4,9,11-trien-3-one | increases expression | ISO | RGD:1318707 | 6480464 | Metribolone results in increased expression of DLG5 mRNA | CTD | PMID:17010196 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:1318708 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of DLG5 mRNA | CTD | PMID:19465110 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of DLG5 mRNA | CTD | PMID:33387578 | 4-hydroxyphenyl retinamide | increases expression | ISO | RGD:1318708 | 6480464 | Fenretinide results in increased expression of DLG5 mRNA | CTD | PMID:28973697 | 6-propyl-2-thiouracil | increases expression | EXP | | 6480464 | Propylthiouracil results in increased expression of DLG5 mRNA | CTD | PMID:30047161 | aconitine | increases expression | EXP | | 6480464 | Aconitine results in increased expression of DLG5 protein | CTD | PMID:33236894 | acrylamide | decreases expression | EXP | | 6480464 | Acrylamide results in decreased expression of DLG5 mRNA | CTD | PMID:28959563 | acrylamide | decreases expression | ISO | RGD:1318707 | 6480464 | Acrylamide results in decreased expression of DLG5 mRNA | CTD | PMID:32763439 | aflatoxin B1 | increases methylation | ISO | RGD:1318707 | 6480464 | Aflatoxin B1 results in increased methylation of DLG5 exon | CTD | PMID:30157460 | aflatoxin B1 | affects methylation | ISO | RGD:1318707 | 6480464 | Aflatoxin B1 affects the methylation of DLG5 intron | CTD | PMID:30157460 | Aflatoxin B2 alpha | increases methylation | ISO | RGD:1318707 | 6480464 | aflatoxin B2 results in increased methylation of DLG5 intron | CTD | PMID:30157460 | all-trans-retinoic acid | decreases expression | ISO | RGD:1318707 | 6480464 | Tretinoin results in decreased expression of DLG5 mRNA | CTD | PMID:33167477 | amitrole | increases expression | EXP | | 6480464 | Amitrole results in increased expression of DLG5 mRNA | CTD | PMID:30047161 | antirheumatic drug | increases expression | ISO | RGD:1318707 | 6480464 | Antirheumatic Agents results in increased expression of DLG5 mRNA | CTD | PMID:24449571 | arsane | affects methylation | ISO | RGD:1318707 | 6480464 | Arsenic affects the methylation of DLG5 gene | CTD | PMID:25304211 | arsenic atom | affects methylation | ISO | RGD:1318707 | 6480464 | Arsenic affects the methylation of DLG5 gene | CTD | PMID:25304211 | arsenite(3-) | multiple interactions | ISO | RGD:1318707 | 6480464 | arsenite inhibits the reaction [G3BP1 protein binds to DLG5 mRNA] | CTD | PMID:32406909 | atrazine | increases expression | ISO | RGD:1318707 | 6480464 | Atrazine results in increased expression of DLG5 mRNA | CTD | PMID:22378314 | benzo[a]pyrene | increases expression | ISO | RGD:1318708 | 6480464 | Benzo(a)pyrene results in increased expression of DLG5 mRNA | CTD | PMID:19770486 | benzo[a]pyrene | decreases methylation | ISO | RGD:1318708 | 6480464 | Benzo(a)pyrene results in decreased methylation of DLG5 exon, Benzo(a)pyrene results in decreased methylation of DLG5 intron | CTD | PMID:27901495 | benzo[e]pyrene | decreases methylation | ISO | RGD:1318707 | 6480464 | benzo(e)pyrene results in decreased methylation of DLG5 intron | CTD | PMID:30157460 | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of DLG5 mRNA | CTD | PMID:30816183 | butanal | decreases expression | ISO | RGD:1318707 | 6480464 | butyraldehyde results in decreased expression of DLG5 mRNA | CTD | PMID:26079696 | cadmium dichloride | decreases methylation | EXP | | 6480464 | Cadmium Chloride results in decreased methylation of DLG5 promoter | CTD | PMID:22457795 | caffeine | affects phosphorylation | ISO | RGD:1318707 | 6480464 | Caffeine affects the phosphorylation of DLG5 protein | CTD | PMID:35688186 | CGP 52608 | multiple interactions | ISO | RGD:1318707 | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to DLG5 gene] | CTD | PMID:28238834 | chlorpyrifos | increases expression | ISO | RGD:1318708 | 6480464 | Chlorpyrifos results in increased expression of DLG5 mRNA | CTD | PMID:37019170 | cisplatin | increases expression | ISO | RGD:1318707 | 6480464 | Cisplatin results in increased expression of DLG5 mRNA | CTD | PMID:27594783 | coumarin | increases phosphorylation | ISO | RGD:1318707 | 6480464 | coumarin results in increased phosphorylation of DLG5 protein | CTD | PMID:35688186 | CU-O LINKAGE | decreases expression | ISO | RGD:1318707 | 6480464 | cupric oxide results in decreased expression of DLG5 mRNA | CTD | PMID:22077320 | cyclosporin A | increases expression | ISO | RGD:1318707 | 6480464 | Cyclosporine results in increased expression of DLG5 mRNA | CTD | PMID:25562108 | diazinon | affects expression | EXP | | 6480464 | Diazinon affects the expression of DLG5 mRNA | CTD | PMID:22546817 | dibutyl phthalate | decreases expression | EXP | | 6480464 | Dibutyl Phthalate results in decreased expression of DLG5 mRNA | CTD | PMID:21266533 | dibutyl phthalate | decreases expression | ISO | RGD:1318708 | 6480464 | Dibutyl Phthalate results in decreased expression of DLG5 mRNA | CTD | PMID:21266533 | dicrotophos | increases expression | ISO | RGD:1318707 | 6480464 | dicrotophos results in increased expression of DLG5 mRNA | CTD | PMID:28302478 | dieldrin | affects expression | EXP | | 6480464 | Dieldrin affects the expression of DLG5 mRNA | CTD | PMID:22546817 | epoxiconazole | decreases expression | ISO | RGD:1318708 | 6480464 | epoxiconazole results in decreased expression of DLG5 mRNA | CTD | PMID:35436446 | ethanol | increases expression | ISO | RGD:1318708 | 6480464 | Ethanol results in increased expression of DLG5 mRNA | CTD | PMID:30319688 | ethanol | affects expression | ISO | RGD:1318708 | 6480464 | Ethanol affects the expression of DLG5 mRNA | CTD | PMID:30319688 | ethyl methanesulfonate | increases expression | ISO | RGD:1318707 | 6480464 | Ethyl Methanesulfonate results in increased expression of DLG5 mRNA | CTD | PMID:23649840 | fenthion | decreases expression | ISO | RGD:1318708 | 6480464 | Fenthion results in decreased expression of DLG5 mRNA | CTD | PMID:34813904 | formaldehyde | increases expression | ISO | RGD:1318707 | 6480464 | Formaldehyde results in increased expression of DLG5 mRNA | CTD | PMID:23649840 | genistein | increases expression | ISO | RGD:1318707 | 6480464 | Genistein results in increased expression of DLG5 mRNA | CTD | PMID:23019147 | gentamycin | decreases expression | EXP | | 6480464 | Gentamicins results in decreased expression of DLG5 mRNA | CTD | PMID:33387578 | hydrogen peroxide | increases expression | ISO | RGD:1318707 | 6480464 | Hydrogen Peroxide results in increased expression of DLG5 mRNA | CTD | PMID:18951874 | isotretinoin | increases expression | ISO | RGD:1318707 | 6480464 | Isotretinoin results in increased expression of DLG5 mRNA | CTD | PMID:20436886 | lead diacetate | decreases expression | ISO | RGD:1318708 | 6480464 | lead acetate results in decreased expression of DLG5 mRNA | CTD | PMID:21829687 | medroxyprogesterone acetate | increases expression | ISO | RGD:1318707 | 6480464 | Medroxyprogesterone Acetate results in increased expression of DLG5 mRNA | CTD | PMID:18497975, PMID:19146866 | methapyrilene | decreases methylation | ISO | RGD:1318707 | 6480464 | Methapyrilene results in decreased methylation of DLG5 intron | CTD | PMID:30157460 | methidathion | decreases expression | ISO | RGD:1318708 | 6480464 | methidathion results in decreased expression of DLG5 mRNA | CTD | PMID:34813904 | methimazole | increases expression | EXP | | 6480464 | Methimazole results in increased expression of DLG5 mRNA | CTD | PMID:30047161 | methoxyacetic acid | multiple interactions | ISO | RGD:1318707 | 6480464 | methoxyacetic acid promotes the reaction [Promegestone results in increased expression of DLG5 mRNA] | CTD | PMID:15103026 | methyl methanesulfonate | increases expression | ISO | RGD:1318707 | 6480464 | Methyl Methanesulfonate results in increased expression of DLG5 mRNA | CTD | PMID:23649840 | nickel dichloride | affects expression | EXP | | 6480464 | nickel chloride affects the expression of DLG5 mRNA | CTD | PMID:22546817 | oxaliplatin | multiple interactions | EXP | | 6480464 | [oxaliplatin co-treated with Topotecan] results in increased expression of DLG5 mRNA | CTD | PMID:25729387 | paracetamol | affects expression | ISO | RGD:1318708 | 6480464 | Acetaminophen affects the expression of DLG5 mRNA | CTD | PMID:17562736 | paracetamol | increases expression | ISO | RGD:1318707 | 6480464 | Acetaminophen results in increased expression of DLG5 mRNA | CTD | PMID:21420995, PMID:22230336 | pentachlorophenol | increases expression | ISO | RGD:1318708 | 6480464 | Pentachlorophenol results in increased expression of DLG5 mRNA | CTD | PMID:23892564 | pirinixic acid | multiple interactions | ISO | RGD:1318707 | 6480464 | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of DLG5 mRNA | CTD | PMID:19710929 | progesterone | multiple interactions | ISO | RGD:1318707 | 6480464 | [Estradiol co-treated with Progesterone] results in increased expression of DLG5 mRNA | CTD | PMID:20660070 | progesterone | increases expression | ISO | RGD:1318707 | 6480464 | Progesterone results in increased expression of DLG5 mRNA | CTD | PMID:18497975 | promegestone | multiple interactions | ISO | RGD:1318707 | 6480464 | methoxyacetic acid promotes the reaction [Promegestone results in increased expression of DLG5 mRNA] | CTD | PMID:15103026 | promegestone | increases expression | ISO | RGD:1318707 | 6480464 | Promegestone results in increased expression of DLG5 mRNA | CTD | PMID:15103026 | sulfadimethoxine | increases expression | EXP | | 6480464 | Sulfadimethoxine results in increased expression of DLG5 mRNA | CTD | PMID:30047161 | topotecan | multiple interactions | EXP | | 6480464 | [oxaliplatin co-treated with Topotecan] results in increased expression of DLG5 mRNA | CTD | PMID:25729387 | trichostatin A | affects expression | ISO | RGD:1318707 | 6480464 | trichostatin A affects the expression of DLG5 mRNA | CTD | PMID:28542535 | valproic acid | increases expression | ISO | RGD:1318708 | 6480464 | Valproic Acid results in increased expression of DLG5 mRNA | CTD | PMID:21427059 | valproic acid | decreases palmitoylation | ISO | RGD:1318708 | 6480464 | Valproic Acid results in decreased palmitoylation of DLG5 protein | CTD | PMID:26348896 | valproic acid | affects expression | ISO | RGD:1318707 | 6480464 | Valproic Acid affects the expression of DLG5 mRNA | CTD | PMID:25979313 | valproic acid | decreases methylation | ISO | RGD:1318707 | 6480464 | Valproic Acid results in decreased methylation of DLG5 gene | CTD | PMID:29154799 | valproic acid | decreases expression | ISO | RGD:1318708 | 6480464 | Valproic Acid results in decreased expression of DLG5 mRNA | CTD | PMID:21427059 | zalcitabine | multiple interactions | EXP | | 6480464 | [gp120 protein, Human immunodeficiency virus 1 co-treated with Zalcitabine] results in increased expression of DLG5 mRNA | CTD | PMID:18606552 | |